FDA Approves Genentech’s Susvimo: New Hope for Diabetic Retinopathy Patients!

Did you know?
The FDA has just approved Genentech’s Susvimo for diabetic retinopathy!

This breakthrough treatment helps nearly 10 million Americans at risk of vision loss—
with only one procedure every nine months!

Unlike monthly eye injections, Susvimo uses an innovative Port Delivery Platform—
a tiny implant that slowly releases medicine right inside the eye.

Clinical studies show Susvimo not only preserves vision, but also reduces the progression of diabetic retinopathy—
with fewer trips to the doctor!

But remember, like any procedure, there are risks, so always consult your eye specialist.

For more information, visit Susvimo.com or Genentech.com.

Don’t forget to share and subscribe for more Uni Network Group health updates!
#FDA #Genentech #Susvimo #DiabeticRetinopathy #EyeHealth #MedicalNews #VisionCare #HealthUpdate #UniNetworkGroup #Shorts #Subscribe

Видео FDA Approves Genentech’s Susvimo: New Hope for Diabetic Retinopathy Patients! канала UNI NETWORK GROUP